|
US2799241A
(en)
|
1949-01-21 |
1957-07-16 |
Wisconsin Alumni Res Found |
Means for applying coatings to tablets or the like
|
|
US4160861A
(en)
|
1977-10-03 |
1979-07-10 |
Merck & Co., Inc. |
Method for the separation of antibiotic macrolides
|
|
US4584369A
(en)
|
1981-07-31 |
1986-04-22 |
Sloan-Kettering Institute For Cancer Research |
Anti-leukemic beta-glycosyl C-nucleosides
|
|
JPS5939889A
(ja)
|
1982-08-30 |
1984-03-05 |
Noguchi Kenkyusho |
２，４，６↓−トリ↓−０↓−アセチル↓−３↓−デオキシ↓−ヘキソノ↓−１，５↓−ラクトンの製造方法
|
|
JP2544609B2
(ja)
|
1986-10-07 |
1996-10-16 |
和光純薬工業株式会社 |
Ｔｃｎｑ錯体
|
|
CA1327013C
(en)
|
1988-06-23 |
1994-02-15 |
Peter Rex Brawn |
Cosmetic composition
|
|
JP2786896B2
(ja)
|
1988-08-19 |
1998-08-13 |
ワーナー―ランバート・コンパニー |
置換されたジヒドロイソキノリノンおよび関連化合物
|
|
DK0472502T3
(da)
|
1990-08-24 |
1995-10-09 |
Spirig Ag |
Fremgangsmåde til fremstilling af pellets
|
|
JPH04253974A
(ja)
|
1991-02-05 |
1992-09-09 |
Ishihara Sangyo Kaisha Ltd |
スルホニル尿素系化合物、それらの製造方法及びそれらを含有する除草剤
|
|
EP0517969A1
(en)
|
1991-06-10 |
1992-12-16 |
AUSIMONT S.p.A. |
Process for increasing the bleaching efficiency of an inorganic persalt or of hydrogen peroxide
|
|
US5149838A
(en)
|
1991-09-20 |
1992-09-22 |
Merck & Co., Inc. |
Intermediates for substituted azetidinones useful as anti-inflammatory and antidegenerative agents
|
|
US5610294A
(en)
|
1991-10-11 |
1997-03-11 |
The Du Pont Merck Pharmaceutical Company |
Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
|
|
CN1071924A
(zh)
|
1991-10-29 |
1993-05-12 |
纳幕尔杜邦公司 |
除草的三唑羧酸酰胺
|
|
GB9208161D0
(en)
|
1992-04-14 |
1992-05-27 |
Pfizer Ltd |
Indoles
|
|
US5334225A
(en)
|
1992-07-15 |
1994-08-02 |
Kao Corporation |
Keratinous fiber dye composition containing a 2-substituted amino-5-alkylphenol derivative coupler
|
|
US5731292A
(en)
|
1992-11-12 |
1998-03-24 |
Tanabe Seiyaku Co., Ltd. |
Dihydrochalcone derivatives which are hypoglycemic agents
|
|
CA2102591C
(en)
|
1992-11-12 |
2000-12-26 |
Kenji Tsujihara |
Hypoglycemic agent
|
|
DE4243279A1
(de)
|
1992-12-21 |
1994-06-23 |
Bayer Ag |
Substituierte Triole
|
|
US6297363B1
(en)
|
1993-02-12 |
2001-10-02 |
Nomura Co., Ltd. |
Glycoside indoles
|
|
JPH06256354A
(ja)
|
1993-03-01 |
1994-09-13 |
Nippon Nohyaku Co Ltd |
新規テトラゾール化合物及びその製法
|
|
JP3187611B2
(ja)
|
1993-05-17 |
2001-07-11 |
キヤノン株式会社 |
液晶性化合物、これを含む液晶組成物、それを有する液晶素子、それらを用いた表示方法および表示装置
|
|
JPH07242526A
(ja)
|
1994-03-03 |
1995-09-19 |
Sogo Yatsukou Kk |
化粧料
|
|
US5830873A
(en)
|
1994-05-11 |
1998-11-03 |
Tanabe Seiyaku Co., Ltd. |
Propiophenone derivative and a process for preparing the same
|
|
US5780483A
(en)
|
1995-02-17 |
1998-07-14 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
|
JP2002500618A
(ja)
|
1995-10-31 |
2002-01-08 |
イーライ・リリー・アンド・カンパニー |
抗血栓性ジアミン
|
|
JP3059088B2
(ja)
|
1995-11-07 |
2000-07-04 |
田辺製薬株式会社 |
プロピオフェノン誘導体およびその製法
|
|
US5723495A
(en)
|
1995-11-16 |
1998-03-03 |
The University Of North Carolina At Chapel Hill |
Benzamidoxime prodrugs as antipneumocystic agents
|
|
JPH09263549A
(ja)
|
1996-01-25 |
1997-10-07 |
Fujisawa Pharmaceut Co Ltd |
ベンゼン誘導体の製造法
|
|
IL121525A0
(en)
|
1996-08-26 |
1998-02-08 |
Tanabe Seiyaku Co |
Process for preparing optically active benzothiazepine compound and intermediate therefor
|
|
ATE216704T1
(de)
|
1996-12-26 |
2002-05-15 |
Tanabe Seiyaku Co |
Propiophenonderivate und verfahren zu ihrer herstellung
|
|
US6153632A
(en)
|
1997-02-24 |
2000-11-28 |
Rieveley; Robert B. |
Method and composition for the treatment of diabetes
|
|
WO1998042347A1
(en)
|
1997-03-25 |
1998-10-01 |
Takeda Chemical Industries, Ltd. |
Pharmaceutical composition containing a phosphorylamide and an ayntibiotic
|
|
WO1999047128A1
(en)
|
1998-03-19 |
1999-09-23 |
Bristol-Myers Squibb Company |
Biphasic controlled release delivery system for high solubility pharmaceuticals and method
|
|
FR2780403B3
(fr)
|
1998-06-24 |
2000-07-21 |
Sanofi Sa |
Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant
|
|
JP2000034239A
(ja)
|
1998-07-16 |
2000-02-02 |
Asahi Glass Co Ltd |
トリフルオロメチル化芳香族化合物の製造方法
|
|
JP3857429B2
(ja)
|
1998-07-17 |
2006-12-13 |
ポーラ化成工業株式会社 |
含硫黄抗真菌剤
|
|
US6069238A
(en)
|
1998-09-30 |
2000-05-30 |
Eli Lilly And Company |
Spirocyclic C-glycosides
|
|
DE69926148D1
(en)
|
1998-11-09 |
2005-08-18 |
Black James Foundation |
Gastrin und cholecystokinin rezeptor ligande
|
|
WO2000028989A1
(en)
|
1998-11-12 |
2000-05-25 |
Smithkline Beecham P.L.C. |
Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
|
|
US20020032164A1
(en)
|
1998-12-30 |
2002-03-14 |
Dale Roderic M. K. |
Antimicrobial compounds and methods for their use
|
|
GB9912961D0
(en)
|
1999-06-03 |
1999-08-04 |
Pfizer Ltd |
Metalloprotease inhibitors
|
|
US6515117B2
(en)
|
1999-10-12 |
2003-02-04 |
Bristol-Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
|
PH12000002657B1
(en)
|
1999-10-12 |
2006-02-21 |
Bristol Myers Squibb Co |
C-aryl glucoside SGLT2 inhibitors
|
|
BR0015294A
(pt)
|
1999-11-03 |
2003-07-15 |
Bristol Myers Squibb Co |
Método para tratamento da diabetes
|
|
JP3450810B2
(ja)
|
2000-01-31 |
2003-09-29 |
キヤノン株式会社 |
脂肪族ポリエステル、脂肪族ポリエステルの製造方法およびセルロースの再資源化方法
|
|
US6627611B2
(en)
|
2000-02-02 |
2003-09-30 |
Kotobuki Pharmaceutical Co Ltd |
C-glycosides and preparation of thereof as antidiabetic agents
|
|
JP4456768B2
(ja)
|
2000-02-02 |
2010-04-28 |
壽製薬株式会社 |
Ｃ−配糖体を含有する薬剤
|
|
WO2001064669A1
(en)
|
2000-03-03 |
2001-09-07 |
Pfizer Products Inc. |
Pyrazole ether derivatives as anti-inflammatory/analgesic agents
|
|
ES2254376T3
(es)
|
2000-03-17 |
2006-06-16 |
Kissei Pharmaceutical Co., Ltd. |
Derivados glucopiranosiloxibencilbenceno, preparaciones medicinales que los contienen e intermediarios para la preparacion de los indicados derivados.
|
|
US6683056B2
(en)
|
2000-03-30 |
2004-01-27 |
Bristol-Myers Squibb Company |
O-aryl glucoside SGLT2 inhibitors and method
|
|
US6555519B2
(en)
|
2000-03-30 |
2003-04-29 |
Bristol-Myers Squibb Company |
O-glucosylated benzamide SGLT2 inhibitors and method
|
|
GB0011098D0
(en)
|
2000-05-08 |
2000-06-28 |
Black James Foundation |
Pharmaceutical compositions comprising protpn pump inhibitors and gastrin/cholecystokinin receptor ligands
|
|
EP1172362A1
(de)
|
2000-07-11 |
2002-01-16 |
Basf Aktiengesellschaft |
Azadioxacycloalkene und ihre Verwendung zur Bekämpfung von Schadpilzen und tierischen Schädlingen
|
|
KR100426030B1
(ko)
|
2000-07-22 |
2004-04-03 |
(주) 한켐 |
락톤계 당화합물에서의 키랄성 전환방법
|
|
AU2001296961A1
(en)
|
2000-09-29 |
2002-04-08 |
Bayer Pharmaceuticals Corporation |
17-beta-hydroxysteroid dehydrogenase-ii inhibitors
|
|
WO2002036602A1
(en)
|
2000-11-02 |
2002-05-10 |
Ajinomoto Co., Inc. |
Novel pyrazole derivatives and diabetes remedies containing the same
|
|
JP2002167430A
(ja)
|
2000-12-01 |
2002-06-11 |
Canon Inc |
脂肪族ポリエステル、脂肪族ポリエステルの製造方法およびデンプンの資源化方法
|
|
US6476352B2
(en)
|
2000-12-18 |
2002-11-05 |
General Electric Company |
Laser beam stop sensor and method for automatically detecting the presence of laser beam stop material using a laser beam stop sensor
|
|
SK287786B6
(sk)
|
2000-12-28 |
2011-09-05 |
Kissei Pharmaceutical Co., Ltd. |
Glukopyranosyloxypyrazolový derivát, farmaceutická kompozícia alebo kombinácia s jeho obsahom a ich použitie
|
|
EP1364957B1
(en)
|
2001-02-26 |
2008-12-31 |
Kissei Pharmaceutical Co., Ltd. |
Glycopyranosyloxypyrazole derivatives and medicinal use thereof
|
|
WO2002068440A1
(en)
|
2001-02-27 |
2002-09-06 |
Kissei Pharmaceutical Co., Ltd. |
Glycopyranosyloxypyrazole derivatives and medicinal use thereof
|
|
WO2002070020A2
(en)
|
2001-03-02 |
2002-09-12 |
University Of Western Ontario |
Polymer precursors of radiolabeled compounds, and methods of making and using the same
|
|
US6936590B2
(en)
|
2001-03-13 |
2005-08-30 |
Bristol Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
|
DK1385856T3
(da)
|
2001-04-11 |
2006-05-15 |
Bristol Myers Squibb Co |
Aminosyrekomplekser af C-aryl-glucosider til behandling af diabetes og fremgangsmåder
|
|
EP1389621A4
(en)
|
2001-04-27 |
2005-05-11 |
Ajinomoto Kk |
N-SUBSTITUTED PYRAZOLYL-O-GLYCOSIDE DERIVATIVES AND DIABETES CONTAINING THEREOF
|
|
GB0112122D0
(en)
|
2001-05-18 |
2001-07-11 |
Lilly Co Eli |
Heteroaryloxy 3-substituted propanamines
|
|
US7105556B2
(en)
|
2001-05-30 |
2006-09-12 |
Bristol-Myers Squibb Company |
Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method
|
|
US7271153B2
(en)
|
2001-06-20 |
2007-09-18 |
Kissei Pharmaceutical Co., Ltd. |
Nitrogenous heterocyclic derivatives, medicinal compositions containing the same, medicinal uses thereof, and intermediates therefor
|
|
JP4115105B2
(ja)
|
2001-07-02 |
2008-07-09 |
協和醗酵工業株式会社 |
ピラゾール誘導体
|
|
WO2003011880A1
(fr)
|
2001-07-31 |
2003-02-13 |
Kissei Pharmaceutical Co., Ltd. |
Derive de glucopyranosyloxybenzylbenzene, composition medicinale contenant ce derive, usage medicinal de cette composition et produit intermediaire pour produire cette composition
|
|
US20030191121A1
(en)
|
2001-08-09 |
2003-10-09 |
Miller Ross A. |
Piperazine carboxamide intermediates of HIV protease inhibitors and processes for their preparation
|
|
US20030087843A1
(en)
|
2001-09-05 |
2003-05-08 |
Washburn William N. |
O-pyrazole glucoside SGLT2 inhibitors and method of use
|
|
ATE312940T1
(de)
|
2001-10-24 |
2005-12-15 |
Michael Burton |
Chromogenischen enzymsubstraten und verfahren zum nachweis von beta-d-ribofuranosidase-wirksamkeit
|
|
PT1443915E
(pt)
|
2001-11-16 |
2006-11-30 |
Bioform Medical Inc |
Composições farmacêuticas e cosméticas contendo aldeídos aromáticos com grupos oxilo
|
|
JP2003238417A
(ja)
|
2002-02-18 |
2003-08-27 |
Nippon Shoyaku Kenkyusho:Kk |
フロレチン配糖体の安定化組成物、該安定化組成物を含有する糖尿病予防・治療剤、および保健食品
|
|
US6617313B1
(en)
|
2002-03-13 |
2003-09-09 |
Council Of Scientific And Industrial Research |
Glucopyranoside and process of isolation thereof from pterocarpus marsupium pharmaceutical composition containing the same and use thereof
|
|
US6562791B1
(en)
|
2002-03-29 |
2003-05-13 |
Council Of Scientific And Industrial Research |
Glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof
|
|
JP2003313168A
(ja)
|
2002-04-18 |
2003-11-06 |
Kirin Brewery Co Ltd |
Ｂｃｌ−２阻害活性を有する化合物およびその化合物のスクリーニング方法
|
|
JP4523775B2
(ja)
|
2002-04-18 |
2010-08-11 |
アストラゼネカ・アクチエボラーグ |
複素環化合物
|
|
DE10231370B4
(de)
|
2002-07-11 |
2006-04-06 |
Sanofi-Aventis Deutschland Gmbh |
Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
|
TWI254635B
(en)
|
2002-08-05 |
2006-05-11 |
Yamanouchi Pharma Co Ltd |
Azulene derivative and salt thereof
|
|
MXPA05000725A
(es)
|
2002-08-09 |
2005-04-08 |
Taisho Pharma Co Ltd |
Procedimiento para la produccion selectiva de aril-5-tio-??-d-aldohexopiranosidos.
|
|
WO2004019958A1
(ja)
|
2002-08-27 |
2004-03-11 |
Kissei Pharmaceutical Co., Ltd. |
ピラゾール誘導体、それを含有する医薬組成物及びその医薬用途
|
|
US7074826B2
(en)
|
2002-10-07 |
2006-07-11 |
Encore Pharmaceuticals, Inc. |
R-NSAID esters and their use
|
|
DE10258008B4
(de)
|
2002-12-12 |
2006-02-02 |
Sanofi-Aventis Deutschland Gmbh |
Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
|
DE10258007B4
(de)
|
2002-12-12 |
2006-02-09 |
Sanofi-Aventis Deutschland Gmbh |
Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
|
PL378324A1
(pl)
|
2003-01-03 |
2006-03-20 |
Bristol-Myers Squibb Company |
Sposób wytwarzania C-aryloglukozydowych inhibitorów SGLT2
|
|
GB0301259D0
(en)
|
2003-01-20 |
2003-02-19 |
Novartis Ag |
Organic compounds
|
|
WO2004076470A2
(en)
|
2003-02-27 |
2004-09-10 |
Bristol-Myers Squibb Company |
A non-cryogenic process for forming glycosides
|
|
ATE510834T1
(de)
|
2003-03-14 |
2011-06-15 |
Astellas Pharma Inc |
C-glykosid-derivate zur behandlung von diabetes
|
|
JP2004300102A
(ja)
|
2003-03-31 |
2004-10-28 |
Kissei Pharmaceut Co Ltd |
縮合複素環誘導体、それを含有する医薬組成物およびその医薬用途
|
|
AU2003902263A0
(en)
|
2003-05-12 |
2003-05-29 |
Fujisawa Pharmaceutical Co., Ltd. |
Monosaccharide compounds
|
|
WO2004113359A1
(ja)
|
2003-06-20 |
2004-12-29 |
Kissei Pharmaceutical Co., Ltd. |
ピラゾール誘導体、それを含有する医薬組成物及びその製造中間体
|
|
NZ545447A
(en)
|
2003-07-23 |
2010-03-26 |
Synta Pharmaceuticals Corp |
Compounds for inflammation and immune-related uses
|
|
CA2549017A1
(en)
|
2003-08-01 |
2005-02-10 |
Mona Patel |
Substituted indazole-o-glucosides
|
|
UA86042C2
(en)
|
2003-08-01 |
2009-03-25 |
Янссен Фармацевтика Н.В. |
Substituted indazole-o-glucosides
|
|
EP1679965A4
(en)
|
2003-08-01 |
2009-05-27 |
Janssen Pharmaceutica Nv |
SUBSTITUTED ANELLIERED HETEROCYCLIC C-GLYCOSIDES
|
|
WO2005012243A2
(en)
|
2003-08-01 |
2005-02-10 |
Janssen Pharmaceutica N.V. |
Substituted indole-o-glucosides
|
|
CN104109155A
(zh)
|
2003-08-01 |
2014-10-22 |
田边三菱制药株式会社 |
新颖化合物
|
|
AU2004261663A1
(en)
|
2003-08-01 |
2005-02-10 |
Janssen Pharmaceutica N.V. |
Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides
|
|
WO2005058845A2
(en)
|
2003-12-19 |
2005-06-30 |
Novo Nordisk A/S |
Novel glucagon antagonists/inverse agonists
|
|
US7157584B2
(en)
|
2004-02-25 |
2007-01-02 |
Takeda Pharmaceutical Company Limited |
Benzimidazole derivative and use thereof
|
|
EA011158B1
(ru)
|
2004-03-16 |
2009-02-27 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Замещённые глюкопиранозилом бензольные производные, содержащие эти соединения лекарственные средства, их применение и способ их получения
|
|
US7393836B2
(en)
|
2004-07-06 |
2008-07-01 |
Boehringer Ingelheim International Gmbh |
D-xylopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture
|
|
WO2006010557A1
(de)
|
2004-07-27 |
2006-02-02 |
Boehringer Ingelheim International Gmbh |
D-glucopyranosyl-phenyl-substituierte cyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
|
WO2006018150A1
(de)
|
2004-08-11 |
2006-02-23 |
Boehringer Ingelheim International Gmbh |
D-xylopyranosyl-phenyl-substituierte cyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
|
TW200637839A
(en)
|
2005-01-07 |
2006-11-01 |
Taisho Pharmaceutical Co Ltd |
1-thio-d-glucitol derivatives
|
|
US20090124702A1
(en)
|
2005-01-25 |
2009-05-14 |
Pechetti Siva Satya Krishna Babu |
Pharmaceutical Compositions of Metformin
|
|
AR053329A1
(es)
|
2005-01-31 |
2007-05-02 |
Tanabe Seiyaku Co |
Derivados de indol utiles como inhibidores de los transportadores de glucosa dependientes del sodio (sglt)
|
|
JP5264183B2
(ja)
|
2005-02-23 |
2013-08-14 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
グルコピラノシル置換（（ヘテロ）アリールエチニル−ベンジル）−ベンゼン誘導体及びナトリウム依存性グルコース共輸送体２（ｓｇｌｔ２）インヒビターとしてのそれらの使用
|
|
WO2006108842A1
(en)
|
2005-04-15 |
2006-10-19 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted (heteroaryloxy-benzyl)-benzene derivatives as sglt inhibitors
|
|
US7772191B2
(en)
|
2005-05-10 |
2010-08-10 |
Boehringer Ingelheim International Gmbh |
Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
|
|
EP1910390B1
(en)
|
2005-07-27 |
2010-05-19 |
Boehringer Ingelheim International GmbH |
Glucopyranosyl-substituted ((hetero)cycloalyklethynyl-benzyl)-benzene derivatives and use thereof as sodium-dependent glucose cotransporter (sglt) inhibitors
|
|
JP5175191B2
(ja)
|
2005-08-30 |
2013-04-03 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
グリコピラノシル置換ベンジルベンゼン誘導体、該化合物を含有する医薬品及びその使用と製造方法
|
|
AR056195A1
(es)
|
2005-09-15 |
2007-09-26 |
Boehringer Ingelheim Int |
Procedimientos para preparar derivados de (etinil-bencil)-benceno sustituidos de glucopiranosilo y compuestos intermedios de los mismos
|
|
CA2640090A1
(en)
|
2006-01-25 |
2007-08-02 |
Synta Pharmaceuticals Corp. |
Substituted aromatic compounds for inflammation and immune-related uses
|
|
TWI418556B
(zh)
|
2006-07-27 |
2013-12-11 |
Mitsubishi Tanabe Pharma Corp |
吲哚衍生物
|
|
CA2656847A1
(en)
|
2006-08-15 |
2008-02-21 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as sglt inhibitors and process for their manufacture
|
|
CA2664095A1
(en)
|
2006-09-21 |
2008-03-27 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted difluorobenzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
|
|
AR063569A1
(es)
|
2006-11-06 |
2009-02-04 |
Boehringer Ingelheim Int |
Derivados de benzil- benzonitrilo sustituidos con glucopiranosilo medicamentos que contienen a compuestos de este tipo su uso u procedimiento para su fabricacion
|
|
CL2007003227A1
(es)
|
2006-11-09 |
2008-07-04 |
Boehringer Ingelheim Int |
Composicion farmaceutica que comprende un derivado de benceno sustituido con glucopiranosilo en combinacion con uno o mas agentes terapeuticos; y uso para el tratamiento de diabetes mellitus, obesidad e hiperglucemia entre otras.
|
|
NZ577391A
(en)
|
2006-12-04 |
2011-11-25 |
Janssen Pharmaceutica Nv |
Thienyl-containing glycopyranosyl derivatives as antidiabetics
|
|
UY30730A1
(es)
|
2006-12-04 |
2008-07-03 |
Mitsubishi Tanabe Pharma Corp |
Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno
|
|
EP1956023A1
(en)
|
2007-02-06 |
2008-08-13 |
Lonza Ag |
Method for lithium exchange reactions
|
|
TW200904405A
(en)
*
|
2007-03-22 |
2009-02-01 |
Bristol Myers Squibb Co |
Pharmaceutical formulations containing an SGLT2 inhibitor
|
|
CL2008002425A1
(es)
|
2007-08-16 |
2009-09-11 |
Boehringer Ingelheim Int |
Composición farmacéutica que comprende un inhibidor de sglt2 y 1-(4-metil-quinazolin-2-il)metil-3metil-7-(-2-butin-1-il)-8-(3-(r)-amino-piperidin-1il)-xantina, un inhibidor de dpp iv y su uso para el tratamiento de la obesidad y de la diabetes tipo 1 y 2 y complicaciones de esta.
|
|
AU2008288770B2
(en)
|
2007-08-23 |
2014-06-12 |
Theracosbio, Llc |
Benzylbenzene derivatives and methods of use
|
|
MX2010002695A
(es)
|
2007-09-10 |
2010-04-01 |
Janssen Pharmaceutica Nv |
Proceso para la preparacion de compuestos utiles como inhibidores de transportador de glucosa dependiente de sodio (sglt).
|
|
CL2008003653A1
(es)
|
2008-01-17 |
2010-03-05 |
Mitsubishi Tanabe Pharma Corp |
Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
|
|
PE20140960A1
(es)
|
2008-04-03 |
2014-08-15 |
Boehringer Ingelheim Int |
Formulaciones que comprenden un inhibidor de dpp4
|
|
US20090304789A1
(en)
*
|
2008-06-09 |
2009-12-10 |
Thomas Najarian |
Novel topiramate compositions and an escalating dosing strategy for treating obesity and related disorders
|
|
US9056850B2
(en)
|
2008-10-17 |
2015-06-16 |
Janssen Pharmaceutica N.V. |
Process for the preparation of compounds useful as inhibitors of SGLT
|
|
WO2010045656A2
(en)
|
2008-10-17 |
2010-04-22 |
Nectid, Inc. |
Novel sglt2 inhibitor dosage forms
|
|
MX339194B
(es)
|
2009-02-13 |
2016-05-16 |
Boehringer Ingelheim Int |
Composicion farmaceutica que comprende un inhibidor de sglt2, un inhibidor de dpp-iv y opcionalmente otro agente antidiabetico, y usos de la misma.
|
|
US20100331999A1
(en)
*
|
2009-06-29 |
2010-12-30 |
Aronne Louis J |
Combination Therapies for the Treatment of Obesity
|
|
US20110009347A1
(en)
|
2009-07-08 |
2011-01-13 |
Yin Liang |
Combination therapy for the treatment of diabetes
|
|
WO2011047113A1
(en)
|
2009-10-14 |
2011-04-21 |
Janssen Pharmaceutica Nv |
Process for the preparation of compounds useful as inhibitors of sglt2
|
|
NZ703128A
(en)
|
2010-05-11 |
2016-04-29 |
Janssen Pharmaceutica Nv |
Pharmaceutical formulations comprising 1 - (beta-d-glucopyranosyl) - 2 -thienylmethylbenzene derivatives as inhibitors of sglt
|
|
JP5596799B2
(ja)
*
|
2010-05-11 |
2014-09-24 |
田辺三菱製薬株式会社 |
カナグリフロジン含有錠剤
|